Related Experiment Video
Updated: Jul 7, 2026
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Control of medically refractory restless legs syndrome with intrathecal morphine: case report
Donald A Ross1, Michael S Narus, John G Nutt
1Medford Neurological Clinic, Medford, Oregon 97504, USA. drdoom867@yahoo.com
Objective:
Restless legs syndrome is now widely recognized and is usually successfully treated with medication. Occasionally, it may be severe and refractory to medication. Intrathecal opiates have been previously described to be useful in this situation in a single report.
Clinical Presentation:
We report the successful use of low-dose intrathecal morphine in a severe case of restless legs syndrome refractory to medication.
Technique:
The surgery was complicated by extreme restlessness in the recovery room resulting in withdrawal or breakage of the catheter on multiple occasions. Relief of symptoms was lost with each catheter malfunction. We describe the possible origin of this complication and a solution to the problem resulting in the successful control of symptoms for 7 months since the last surgery.
Conclusion:
Intrathecal opiates for restless legs syndrome are currently considered investigational, but we hope, with this second report of the efficacy of low-dose intrathecal narcotics in this condition, to stimulate further investigation of this treatment modality.
More Related Videos
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:29Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...